4.7 Review

PML diagnostic criteria Consensus statement from the AAN Neuroinfectious Disease Section

Journal

NEUROLOGY
Volume 80, Issue 15, Pages 1430-1438

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31828c2fa1

Keywords

-

Funding

  1. CMSC
  2. AAN
  3. Bayer
  4. BiogenIdec
  5. PML Consortium
  6. NIH [U10 NS077384, MH22005, AI25903, R56-NS041198, R01-NS047029, R01-NS074995, K24-NS060950]
  7. Alzheimer Association
  8. Biogen Idec
  9. NeurogesX
  10. Tibotec
  11. Pfizer
  12. University of Kentucky and CMSC/ACTRIMS
  13. ECTRIMS
  14. National MS Society
  15. Bristol-Myers Squibb
  16. Ono Pharmaceuticals
  17. Merck Serono
  18. Hoffmann La Roche
  19. GlaxoSmithKline
  20. Perseid Therapeutics
  21. Vertex Pharmaceutical
  22. Johnson Johnson

Ask authors/readers for more resources

Objective: To establish criteria for the diagnosis of progressive multifocal leukoencephalopathy (PML). Methods: We reviewed available literature to identify various diagnostic criteria employed. Several search strategies employing the terms progressive multifocal leukoencephalopathy with or without JC virus were performed with PubMed, SCOPUS, and EMBASE search engines. The articles were reviewed by a committee of individuals with expertise in the disorder in order to determine the most useful applicable criteria. Results: A consensus statement was developed employing clinical, imaging, pathologic, and virologic evidence in support of the diagnosis of PML. Two separate pathways, histopathologic and clinical, for PML diagnosis are proposed. Diagnostic classification includes certain, probable, possible, and not PML. Conclusion: Definitive diagnosis of PML requires neuropathologic demonstration of the typical histopathologic triad (demyelination, bizarre astrocytes, and enlarged oligodendroglial nuclei) coupled with the techniques to show the presence of JC virus. The presence of clinical and imaging manifestations consistent with the diagnosis and not better explained by other disorders coupled with the demonstration of JC virus by PCR in CSF is also considered diagnostic. Algorithms for establishing the diagnosis have been recommended.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available